Taken together, our TBX2 inhibition studies in malignant breast carcinoma cell lines reinforce the notion that TBX2 promotes malignant tumor progression by imparting a highly invasive mesenchymal phenotype on breast epithelial tumor cells. The gene discussed is TBX2; the disease is breast carcinoma.